https://seekingalpha.com/article/4764949-jazz-buys-chimerix-a-good-deal-to-make-with-major-approval-catalyst-in-play [Seeking Alpha]
Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ)
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
jazzpharma.com
Company Research
Source: Seeking Alpha
Jazz's acquisition aims to counter competitive threats and patent expirations, leveraging its established sales infrastructure for ONC201's potential approval. ONC201, targeting H3 K27M-mutant diffuse glioma, could generate significant revenues, with peak sales estimates ranging from $200m to $1bn annually. This strategic move aligns with Jazz's goal to diversify and drive long-term growth, potentially boosting revenues to over $5bn by 2030. Anton Vierietin Investment Overview News broke earlier today that Jazz Pharmaceuticals ( NASDAQ: JAZZ ), the Dublin, Ireland based commercial stage Pharma, is set to acquire Chimerix ( NASDAQ: CMRX ), based in Durham, NC, in a deal worth ~$935m, or $8.55 per share, paid in cash. If you like what you have just read and want to receive at least 4 exclusive stock tips every week focused on Pharma, Biotech and Healthcare, then join me at my marketplace channel, Haggerston BioHealth . Invest alongside the model portfolio or simply access t
Show less
Read more
Impact Snapshot
Event Time:
JAZZ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JAZZ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JAZZ alerts
High impacting Jazz Pharmaceuticals plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
JAZZ
News
- Is It Too Late To Consider Jazz Pharmaceuticals After Its Strong 2024 Share Price Rally? [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals to Participate in Upcoming Investor Events [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals to Participate in Upcoming Investor EventsPR Newswire
- Jazz Pharmaceuticals to Participate in Upcoming Investor EventsPR Newswire
- 3 Value Stocks We're Skeptical Of [Yahoo! Finance]Yahoo! Finance
JAZZ
Earnings
- 11/5/25 - Beat
JAZZ
Sec Filings
- 12/11/25 - Form 4
- 12/10/25 - Form 3
- 12/9/25 - Form 144
- JAZZ's page on the SEC website